1. Patients with mild or moderate COPD (chronic obstructive pulmonary disease) randomized to receive tiotropium had a significantly higher FEV1...

1. Dietary quality, scored against three well validated dietary rubrics, as well as all-cause mortality were tracked in a large...

1. There were no significant differences at one year regarding hypothyroid-related symptoms or cardiovascular outcomes between patients with subclinical hypothyroidism...

1. There has been concern about the linkage between lithium use during pregnancy and a risk of cardiac malformations, specifically...

1. Baricitinib, an oral, once-daily inhibitor of JAK1 and JAK2, has shown promise in the treatment of rheumatoid arthritis (RA)....

1. In children who suffered in-hospital cardiac arrest, there was no significant difference in 1-year survival in those randomized to...

1. 177Lu-Dotatate, a radiolabeled somatostatin analogue, was associated with increased progression-free survival and decreased overall mortality compared to standard therapy...

1. Ustekinumab achieved successful clinical induction in a greater proportion of patients with moderate to severe Crohn’s disease (CD) compared...

1. There was no mortality benefit associated with receiving long-term oxygen supplementation in patients with stable chronic obstructive pulmonary disease...

1. Hospitals and provider organizations are increasingly compared and benchmarked based on short-term outcome measures, such as the risk-adjusted 30-day...